1. Anti-infection Autophagy
  2. Parasite Influenza Virus Autophagy
  3. Nitazoxanide

Nitazoxanide  (Synonyms: 硝唑尼特; NTZ; NSC 697855)

目录号: HY-B0217 纯度: 99.28%
COA 产品使用指南 技术支持

Nitazoxanide (NTZ) 是一种广谱驱虫剂 (anthelmintic),对感染动物和人类的各种蠕虫、原生动物和肠道细菌都具有作用活性。 Nitazoxanide 在无菌培养中抑制 Giardia lamblia 滋养体增殖,IC50 为 2.4 μM。Nitazoxanide 可用于寄生虫性 (parasitic) 胃肠炎的研究。Nitazoxanide还具有抗病毒特性。 Nitazoxanide 在小鼠模型中显示出抗日本脑炎病毒 (JEV) 活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Nitazoxanide

Nitazoxanide Chemical Structure

CAS No. : 55981-09-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥500
In-stock
1 mg ¥140
In-stock
5 mg ¥281
In-stock
10 mg ¥450
In-stock
50 mg ¥1469
In-stock
100 mg ¥1989
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Nitazoxanide:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Nitazoxanide (NTZ), an anthelmintic agent, exhibits a broad spectrum of activities against a wide variety of helminths, protozoa, and enteric bacteria infecting animals and humans. Nitazoxanide inhibits Giardia lamblia trophozoite proliferation in axenic culture with an IC50 of 2.4 μM[1]. Nitazoxanide can be used for the research of parasitic gastroenteritis. Nitazoxanide shows anti-Japanese encephalitis virus (JEV) activity in a mouse model[2].

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
> 50 μM
Compound: NTZ
Antiproliferative activity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
BHK-21 CC50
25 μM
Compound: 105
Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 16 hrs by CCK-8 assay
Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 16 hrs by CCK-8 assay
[PMID: 28689975]
Caco-2 IC50
221 μM
Compound: Nitazoxanide
Antiprolferative activity against human Caco2 cells assessed as inhibition of cell proliferation by measuring [3H]-thymidine incorporation incubated for 48 hrs by liquid scintillometry
Antiprolferative activity against human Caco2 cells assessed as inhibition of cell proliferation by measuring [3H]-thymidine incorporation incubated for 48 hrs by liquid scintillometry
[PMID: 28601526]
Caco-2 IC50
26.8 μM
Compound: NTZ
Antiproliferative activity against human Caco-2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human Caco-2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
HEK-293T CC50
> 40 μM
Compound: Nitazoxanide
Cytotoxicity against human HEK293T cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay
Cytotoxicity against human HEK293T cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay
[PMID: 29469575]
HeLa IC50
35 μM
Compound: NTZ
Cytotoxicity against human HeLa cells assessed as inhibition of cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as inhibition of cell viability measured after 48 hrs by MTT assay
[PMID: 34055214]
HeLa IC50
35 μM
Compound: NTZ
Antiproliferative activity against human HeLa cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
HepG2 CC50
> 40 μM
Compound: Nitazoxanide
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay
[PMID: 29469575]
HepG2 2.2.15 CC50
> 100 μM
Compound: 1, NTZ
Cytotoxicity against human HepG2(2.2.15) cells after 24 hrs by neutral red dye uptake assay
Cytotoxicity against human HepG2(2.2.15) cells after 24 hrs by neutral red dye uptake assay
[PMID: 21553812]
HL-60 IC50
20.1 μM
Compound: NTZ
Antiproliferative activity against human HL60 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HL60 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
HT-29 IC50
> 50 μM
Compound: NTZ
Antiproliferative activity against human HT29 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HT29 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
Huh-7 CC50
49 μM
Compound: 1, NTZ, PH-5776
Cytotoxicity against human Huh7.5 cells after 3 days by neutral red dye assay
Cytotoxicity against human Huh7.5 cells after 3 days by neutral red dye assay
[PMID: 22059983]
PC-3 IC50
44.7 μM
Compound: NTZ
Antiproliferative activity against human PC3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
[PMID: 34055214]
Peritoneal macrophage IC50
2 mM
Compound: 36, NTZ
Anti-inflammatory activity against mouse peritoneal macrophages assessed as reduction in LPS induced IL-6 level by ELISA analysis
Anti-inflammatory activity against mouse peritoneal macrophages assessed as reduction in LPS induced IL-6 level by ELISA analysis
[PMID: 32992245]
RAW264.7 IC50
1.54 mM
Compound: 36, NTZ
Anti-inflammatory activity against mouse RAW264.7 cells assessed as reduction in LPS induced IL-6 level by ELISA analysis
Anti-inflammatory activity against mouse RAW264.7 cells assessed as reduction in LPS induced IL-6 level by ELISA analysis
[PMID: 32992245]
U2OS CC50
25 μM
Compound: 105
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 16 hrs by CCK-8 assay
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 16 hrs by CCK-8 assay
[PMID: 28689975]
Vero IC50
10.74 μM
Compound: NTZ
Cytotoxicity against african green monkey Vero cells assessed as cell viability after 48 hrs by WST-1 assay
Cytotoxicity against african green monkey Vero cells assessed as cell viability after 48 hrs by WST-1 assay
[PMID: 23787289]
Vero CC50
833 μM
Compound: Nitazoxanide
Cytotoxicity against African green monkey Vero cells after 48 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells after 48 hrs by MTT assay
[PMID: 25801157]
Vero CC50
833 μM
Compound: NIT, Alinia
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
[PMID: 21397502]
Vero CC50
833 μM
Compound: Nitazoxanide
Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
[PMID: 28645659]
Vero CC50
833 μM
Compound: NTZ
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
[PMID: 24529307]
Vero C1008 CC50
> 35.5 μM
Compound: 48
Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay
Cytotoxicity against African green monkey Vero E6 cells by the CCK8 assay
[PMID: 32845145]
体外研究
(In Vitro)

Giardia lamblia,一种有鞭毛的原生动物,是全球范围内持续性腹泻最常见的病原体[1]
Nitazoxanide 在无菌培养环境中对 G. lamblia 滋养体的增殖有抑制作用,IC50 为 2.4 μM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human cancer colon Caco2 cells were incubated with increasing numbers of Giardia lamblia trophozoites (103 to 106 parasites per well)
Concentration: 30 μM
Incubation Time: 24 hours
Result: 70 to 90% of the trophozoites remained attached to the Caco2 cells for a period of 24 to 48 h in the absence of Nitazoxanide and at an initial inoculum density of 105 parasites per well.
The number of parasites still attached to Caco2 cells after 24 h decreased to less than 20% of the control value in the presence of 30 μM Nitazoxanide with an inoculum density of 105 trophozoites.
体内研究
(In Vivo)

Nitazoxanide 在体内对多种肠道寄生虫表现出广泛的活性,例如蓝氏贾第鞭毛虫、溶组织内阿米巴、阴道毛滴虫、顶复门的微小隐孢子虫,以及感染动物和人类的肠道细菌[1]
Nitazoxanide (50、75 或 100 mg/kg/day; 灌胃; 25 天) 可降低感染日本脑炎病毒 (JEV) 毒株的小鼠的死亡率,并保护小鼠免受致死剂量的日本脑炎病毒的攻击[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Three-week old female Chinese Kunming mice (12–14 g body weight) were infected intraperitoneally with JEV[2]
Dosage: 50, 75 or 100 mg/kg/day
Administration: Administered intragastrically by gavage
Result: 50 mg/kg/day, 75 mg/kg/day and 100 mg/kg/day led to 30%, 70% and 90% mice survival, respectively.
分子量

307.28

Formula

C12H9N3O5S

CAS 号
性状

固体

颜色

Light yellow to yellow

中文名称

硝唑尼特

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性数据
细胞实验: 

DMSO 中的溶解度 : ≥ 100 mg/mL (325.44 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.2544 mL 16.2718 mL 32.5436 mL
5 mM 0.6509 mL 3.2544 mL 6.5087 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 3.25 mg/mL (10.58 mM); 澄清溶液

    此方案可获得 ≥ 3.25 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 32.5 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

    生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
请输入您的动物体内配方组成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
连续给药周期超过半月以上,请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
纯度 & 产品资料
参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.2544 mL 16.2718 mL 32.5436 mL 81.3590 mL
5 mM 0.6509 mL 3.2544 mL 6.5087 mL 16.2718 mL
10 mM 0.3254 mL 1.6272 mL 3.2544 mL 8.1359 mL
15 mM 0.2170 mL 1.0848 mL 2.1696 mL 5.4239 mL
20 mM 0.1627 mL 0.8136 mL 1.6272 mL 4.0680 mL
25 mM 0.1302 mL 0.6509 mL 1.3017 mL 3.2544 mL
30 mM 0.1085 mL 0.5424 mL 1.0848 mL 2.7120 mL
40 mM 0.0814 mL 0.4068 mL 0.8136 mL 2.0340 mL
50 mM 0.0651 mL 0.3254 mL 0.6509 mL 1.6272 mL
60 mM 0.0542 mL 0.2712 mL 0.5424 mL 1.3560 mL
80 mM 0.0407 mL 0.2034 mL 0.4068 mL 1.0170 mL
100 mM 0.0325 mL 0.1627 mL 0.3254 mL 0.8136 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Nitazoxanide
目录号:
HY-B0217
需求量: